rs63751163
|
|
Alzheimer disease, familial, type 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
EFNS guidelines for the diagnosis and management of Alzheimer's disease.
|
20831773 |
2010 |
rs63751163
|
|
Alzheimer disease, familial, type 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians.
|
24829003 |
2014 |
rs63751163
|
|
Alzheimer disease, familial, type 3
|
C |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs63751163
|
|
Alzheimer disease, familial, type 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
|
20298421 |
2010 |
rs63751163
|
|
Alzheimer disease, familial, type 3
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Preventing Alzheimer's disease and cognitive decline.
|
21500874 |
2010 |
rs63751163
|
|
Childhood Neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We showed previously that PS1 exon 9 deletion (PS1 DeltaE9) and L250S mutations predispose SH-SY5Y neuroblastoma cells to high glucose stress-induced apoptosis and that the anti-apoptotic effect of insulin-like growth factor I (IGF-I) is compromised by these mutations.
|
11746362 |
2001 |
rs63751163
|
|
Neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We showed previously that PS1 exon 9 deletion (PS1 DeltaE9) and L250S mutations predispose SH-SY5Y neuroblastoma cells to high glucose stress-induced apoptosis and that the anti-apoptotic effect of insulin-like growth factor I (IGF-I) is compromised by these mutations.
|
11746362 |
2001 |
rs63751163
|
|
Alzheimer's Disease
|
|
0.020 |
GeneticVariation
|
BEFREE |
PS1 L250S familial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.
|
9436726 |
1998 |
rs63751163
|
|
Neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
|
10658639 |
2000 |
rs63751163
|
|
Alzheimer's Disease
|
|
0.020 |
GeneticVariation
|
BEFREE |
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
|
10658639 |
2000 |
rs63751163
|
|
Childhood Neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
|
10658639 |
2000 |
rs63751163
|
|
Central neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
|
10658639 |
2000 |
rs63751163
|
|
Central neuroblastoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We showed previously that PS1 exon 9 deletion (PS1 DeltaE9) and L250S mutations predispose SH-SY5Y neuroblastoma cells to high glucose stress-induced apoptosis and that the anti-apoptotic effect of insulin-like growth factor I (IGF-I) is compromised by these mutations.
|
11746362 |
2001 |
rs63751163
|
|
Seizures
|
|
0.010 |
GeneticVariation
|
BEFREE |
PS1 L250S familial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.
|
9436726 |
1998 |
rs63751163
|
|
Familial Alzheimer Disease (FAD)
|
|
0.010 |
GeneticVariation
|
BEFREE |
PS1 L250S familial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.
|
9436726 |
1998 |